Are Th17 cells in the gut pathogenic or protective

Mucosal Immunology

Volumn 5, Issue 1, 2012, Pages 4-6

  Symons, A ^a   Budelsky, A L ^a   Towne, J E ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AIN 457; CD3 ANTIBODY; CD69 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 17F; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; IXEKIZUMAB; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; SECUKINUMAB; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTHRITIS; AUTOIMMUNE DISEASE; CHRONIC INFLAMMATION; COLITIS; CROHN DISEASE; CYTOKINE PRODUCTION; DRUG RESPONSE; HUMAN; IMMUNOLOGICAL TOLERANCE; INTESTINE; MUCOSAL IMMUNITY; MULTIPLE SCLEROSIS; NONHUMAN; PATHOGENICITY; PRIORITY JOURNAL; PROTECTION; PROTEIN EXPRESSION; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; SKIN INFECTION; TH17 CELL; ULCERATIVE COLITIS; UVEITIS;

EID: 83655181156     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2011.51     Document Type: Review

References (14)

1. Spits, H. & Di Santo, J. P. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nat Immunol 12, 21-27 (2011).
2. Hueber, W., et al. Effects of AIN457, a fully human antibody to interleukin-17A, on psoriasis, rheumatoid arthritis, and uveitis. Sci. Transl. Med. 2, 52ra72 (2010).
3. Genovese, M. C., et al. LY2439821, a humanized anti-interleukin-17 monoclonalantibody, in the treatment of patients with rheumatoid arthritis: a phase I randomized, double-blind, placebocontrolled, proof-of-concept study. Arthritis and Rheumatism 62, 929-939 (2010).
4. Ghoreschi, K., Laurence, A., Yang, X. P., Hirahara, K. & OShea, J. J. T helper 17 cell heterogeneity and pathogenicity in autoimmune disease. Trends Immunol 32, 395-401 (2011).
5. Morrison, P. J., Ballantyne, S. J. & Kullberg, M. C. Interleukin-23 and T helper 17-type responses in intestinalinflammation: from cytokines to T-cell plasticity. Immunology 133, 397-408 (2011).
6. Hovhannisyan, Z., Treatman, J., Littman, D. R. & Mayer, L. Characterization of interleukin-17-producing regulatory T cells in inflamed intestinal mucosa from patients with inflammatory bowel diseases. Gastroenterology 140, 957-965 (2011).
7. Hirota, K., et al. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat Immunol 12, 255-263 (2011).
8. Wei, G., et al. Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity 30, 155-167 (2009).
9. OConnor, W. Jr., et al. A protective function for interleukin 17A in T cell-mediated intestinalinflammation. Nat Immunol 10, 603-609 (2009).
10. Esplugues, E., et al. Controlof TH17 cells occurs in the smallintestine. Nature 475, 514-518 (2011).
11. Annunziato, F., et al. Phenotypic and functional features of human Th17 cells. J Exp Med 204, 1849-1861 (2007). (Pubitemid 47240944)
12. Sarra, M., Pallone, F., Macdonald, T. T. & Monteleone, G. IL-23/IL-17 axis in IBD. Inflamm Bowel Dis 16, 1808-1813 (2010).
13. Hueber, W., et al. Inhibition of IL-17A by secukinumab is ineffective for Crohns disease (CD). J Crohns Colitis 5, S7 (2011).
14. Ohnmacht, C., et al. Intestinal microbiota, evolution of the immune system and the bad reputation of pro-inflammatory immunity. Cell Microbiol. 13, 653-659 (2011).